Origene

OriGene Technologies is a research tool company commercializing products and services in the life science and clinical diagnostic segments, in the US, China and Europe. It currently owns the largest commercial collection of full-length human cDNAs in a standard expression vector.

OriGene's vision is to enable scientists and clinicians to study complete biological pathways, thus allowing a better understanding of disease mechanisms including in cancer and stem cell research.

Exit Date: 2016

Origene
Team

Buyout

Status

Divested

Geography

US

Ownership

Minority

Segment

Life Science Tools, MedTech & Diagnostics

Entry Date

2015

Key Figures

Divested

Status

1995

Creation Date

2015

Investment Date

Mérieux Participations 2

Fund Name

2016

Investment’s Exit Date

Key Contacts

Related companies